Total Payments
$17,062
2024 Payments
$1,592
Companies
50
Transactions
521
Medicare Patients
6,695
Medicare Billing
$581,682
Payment Breakdown by Category
Food & Beverage$11,560 (67.8%)
Consulting$3,000 (17.6%)
Travel$1,877 (11.0%)
Education$625.25 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,560 | 491 | 67.8% |
| Consulting Fee | $3,000 | 1 | 17.6% |
| Travel and Lodging | $1,877 | 10 | 11.0% |
| Education | $625.25 | 19 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Valeant Pharmaceuticals North America LLC | $4,314 | 18 | $0 (2017) |
| Dendreon Pharmaceuticals LLC | $2,301 | 67 | $0 (2024) |
| Astellas Pharma US Inc | $1,653 | 61 | $0 (2024) |
| NeoTract Inc. | $1,496 | 12 | $0 (2020) |
| Sumitomo Pharma America, Inc. | $789.69 | 39 | $0 (2024) |
| Janssen Biotech, Inc. | $551.38 | 38 | $0 (2024) |
| Antares Pharma, Inc. | $495.52 | 35 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $489.88 | 28 | $0 (2024) |
| ABBVIE INC. | $451.36 | 21 | $0 (2024) |
| PFIZER INC. | $435.04 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,592 | 68 | Sumitomo Pharma America, Inc. ($300.29) |
| 2023 | $1,831 | 74 | Sumitomo Pharma America, Inc. ($489.40) |
| 2022 | $1,549 | 75 | Dendreon Pharmaceuticals LLC ($307.62) |
| 2021 | $1,380 | 62 | Astellas Pharma US Inc ($339.42) |
| 2020 | $514.38 | 18 | Dendreon Pharmaceuticals LLC ($221.82) |
| 2019 | $2,683 | 75 | NeoTract Inc. ($1,372) |
| 2018 | $1,214 | 55 | Dendreon Pharmaceuticals LLC ($391.26) |
| 2017 | $6,299 | 94 | Valeant Pharmaceuticals North America LLC ($4,314) |
All Payment Transactions
521 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: ONCOLOGY | ||||||
| 12/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/09/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/05/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/18/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/11/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: HORMONE THERAPY | ||||||
| 10/30/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/28/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/17/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.12 | General |
| Category: UROLOGY | ||||||
| 10/10/2024 | Axonics, Inc. | Axonics (Device), Bulkamid | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Urology | ||||||
| 10/02/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: HORMONE THERAPY | ||||||
| 09/19/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Oncology | ||||||
| 09/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,690 | 2,964 | $383,017 | $140,689 |
| 2022 | 31 | 2,170 | 4,139 | $467,890 | $187,554 |
| 2021 | 18 | 1,407 | 2,380 | $310,843 | $119,936 |
| 2020 | 24 | 1,428 | 2,531 | $368,544 | $133,502 |
Total Patients
6,695
Total Services
12,014
Medicare Billing
$581,682
Procedure Codes
94
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 320 | 620 | $107,272 | $40,900 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 212 | 349 | $85,674 | $33,557 | 39.2% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 127 | 157 | $74,239 | $29,657 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 99 | 99 | $33,524 | $12,158 | 36.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 346 | 603 | $15,804 | $4,938 | 31.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 12 | 133 | $12,768 | $3,757 | 29.4% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $7,248 | $2,766 | 38.2% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Office | 2023 | 71 | 82 | $9,706 | $2,581 | 26.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 39 | $4,110 | $1,734 | 42.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $4,969 | $1,608 | 32.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 14 | $5,300 | $1,559 | 29.4% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 12 | 23 | $2,963 | $1,043 | 35.2% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 12 | 16 | $2,582 | $922.30 | 35.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 244 | 381 | $1,596 | $814.28 | 51.0% |
| 52204 | Biopsy of bladder using an endoscope | Facility | 2023 | 11 | 11 | $8,495 | $787.51 | 9.3% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 14 | 14 | $1,976 | $662.76 | 33.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 23 | 25 | $1,140 | $431.48 | 37.8% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 13 | 16 | $2,384 | $313.60 | 13.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 19 | $620.00 | $217.17 | 35.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 49 | 50 | $350.00 | $170.50 | 48.7% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 18 | 276 | $297.36 | $111.65 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 316 | 638 | $95,700 | $42,336 | 44.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 221 | 360 | $75,600 | $33,529 | 44.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 130 | 151 | $63,571 | $28,845 | 45.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 102 | 102 | $35,292 | $11,904 | 33.7% |
About Dr. Ilya Gorbachinsky, M.D
Dr. Ilya Gorbachinsky, M.D is a Urology healthcare provider based in Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2011. The National Provider Identifier (NPI) number assigned to this provider is 1588959977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ilya Gorbachinsky, M.D has received a total of $17,062 in payments from pharmaceutical and medical device companies, with $1,592 received in 2024. These payments were reported across 521 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($11,560).
As a Medicare-enrolled provider, Gorbachinsky has provided services to 6,695 Medicare beneficiaries, totaling 12,014 services with total Medicare billing of $581,682. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Las Vegas, NV
- Active Since 06/14/2011
- Last Updated 07/25/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1588959977
Products in Payments
- PROVENGE (Drug) $6,615
- UroLift (Device) $1,496
- XTANDI (Drug) $837.60
- GEMTESA (Drug) $639.11
- ORGOVYX (Drug) $631.43
- Erleada (Drug) $413.65
- Myrbetriq (Drug) $402.72
- Xtandi (Drug) $396.32
- FIRMAGON (Drug) $376.97
- BOTOX (Biological) $325.26
- XYOSTED (Drug) $260.14
- XGEVA (Biological) $251.69
- XIAFLEX (Biological) $244.97
- NOCDURNA (Drug) $222.73
- MYRBETRIQ (Drug) $214.04
- JELMYTO (Drug) $205.58
- ILLUCCIX (Drug) $158.18
- LUPRON DEPOT (Drug) $145.32
- UROLIFT (Device) $145.22
- SpaceOAR (Device) $132.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Las Vegas
Vijay Goli, M.d, M.D
Urology — Payments: $322,441
Urology $322,441
Joel Abbott, D.o, D.O
Urology — Payments: $115,145
Urology $115,145
Victor Grigoriev, M.d, M.D
Urology — Payments: $75,593
Urology $75,593
Omid Lesani, M.d, M.D
Urology — Payments: $52,856
Urology $52,856
Sheldon Freedman, Md, MD
Urology — Payments: $43,617
Urology $43,617
Michael Verni, M.d, M.D
Urology — Payments: $42,412
Urology $42,412